# Sumitomo Dainippon Pharma Co., Ltd. – FDA Inspection, Jul 11, 2025

Source: https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/959cb516-78a7-4b4f-96f4-d510481d7ed0
Source feed: FDA_Inspections

> FDA inspection 1276963 of Sumitomo Dainippon Pharma Co., Ltd., July 11, 2025. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR parts 211 and 606. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1276963
- Company Name: Sumitomo Dainippon Pharma Co., Ltd.
- Inspection Date: 2025-07-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 8

## Related Documents

- [FDA Inspection 1088923 - 2019-04-16](https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/7a4e397a-ac18-4bee-996b-e502e1b4dad2)
- [FDA Inspection 1003840 - 2017-02-17](https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/5bae5b31-f273-4048-9552-f3d2683edd30)
- FDA Inspection 895955 - 2014-09-12
- FDA Inspection 797370 - 2012-02-24
- FDA Inspection 676813 - 2010-07-30

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)
- [FDA Associated Person](https://www.keypedia.com/people/jessica-s-estriplet/b7152ec3-6e1b-45aa-840e-7147f357aea2)

Company: https://www.keypedia.com/companies/sumitomo-dainippon-pharma-co-ltd/a14dd605-ff5f-4e7a-a71b-73f6eb72a9c6

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8